dostarlimab
gsk
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rectal', 'dostarlimab']
oncologists at #asco22: i implore you not to forget that pathologists are our integral partners in surfacing which patients are most likely to benefit from de-intensified approaches like dostarlimab in msi-high rectal cancer we are currently under-testing even stage iv crc pts! 
Director, GI Oncology, @Intermountain. Interests: neuroendocrine tumors, cancer syndromes, empathy (even had a Whipple myself). Tweets my own.